telehealth

News

Novo hits back at rivals with cut-price Wegovy subscriptions

Trying to claw back market share in the weight-loss category, Novo Nordisk has launched a subscription-based service for Wegovy cash payers.

News

Novo partners with Hims & Hers again, ending GLP-1 spat

Novo Nordisk and Hims & Hers have set their differences aside, agreeing to work together once again on the sale of GLP-1 agonists.

News

FDA ramps up its pushback against compounded GLP-1s

In a move that will please Novo Nordisk and Eli Lilly, the FDA sent warnings to 30 telehealth firms, accusing them of illegally marketing GLP-1 drugs.

Digital

On digital health and the Rural Health Transformation Progra...

As reported in January this year, the United States Centers for Medicare & Medicaid Services (CMS) rolled out $10 billion in

News

Hims & Hers buys Australian digital health firm for $1.15bn

Hims & Hers, facing a threat to its compounded medicines business, has ramped up its push for international expansion by buying Eucalyptus Health.

News

Grail multi-cancer test taps into Hims & Hers network

Grail has teamed up with telehealth company Hims & Hers to boost access to its recently filed Galleri blood test for cancer screening.

Novo hits back at rivals with cut-price Wegovy subscriptions

Novo partners with Hims & Hers again, ending GLP-1 spat

FDA ramps up its pushback against compounded GLP-1s

On digital health and the Rural Health Transformation Progra...

Hims & Hers buys Australian digital health firm for $1.15bn

Grail multi-cancer test taps into Hims & Hers network

NHS to offer Wegovy to a million more people in England

Using AI-driven synthetic personas to take your insights fur...

telehealth

Editor's Picks